1,907
Views
0
CrossRef citations to date
0
Altmetric
Editorial

When is pharmacotherapy necessary for the treatment of seasonal affective disorder?

, & ORCID Icon
Pages 1243-1245 | Received 25 Feb 2022, Accepted 23 Jun 2022, Published online: 12 Jul 2022

References

  • Rosenthal NE, Sack DA, Gillin JC, et al. Seasonal affective disorder - a description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry. 1984;41(1):72–80.
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington (DC): Author; 2013.
  • Lõhmus M. Possible biological mechanisms linking mental health and heat-a contemplative review. Int J Environ Res Public Health. 2018 Jul 18;15(7):1515. PMID: 30021956; PMCID: PMC6068666.
  • Yu J, Yang D, Kim Y, et al. Seasonality of suicide: a multi-country multi-community observational study. Epidemiol Psychiatr Sci. 2020 Aug 24;29:e163. PMID: 32829741; PMCID: PMC7503188.
  • Cools O, Hebbrecht K, Coppens V, et al. Pharmacotherapy and nutritional supplements for seasonal affective disorders: a systematic review. Expert Opin Pharmacother. 2018 Aug;19(11):1221–1233.
  • Moscovitch A, Blashko CA, Eagles JM, et al. A placebo-controlled study of sertraline in the treatment of outpatients with seasonal affective disorder. Psychopharmacology (Berl). 2004;171(4):390–397.
  • Lam RW, Gorman CP, Michalon M, et al. Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder. Am J Psychiatry. 1995;152(12):1765–1770.
  • Nussbaumer-Streit B, Thaler K, Chapman A, et al. Second-generation antidepressants for treatment of seasonal affective disorder. Cochrane Database Syst Rev. 2021 Mar 4;3(3):CD008591.
  • Thaler K, Delivuk M, Chapman A, et al. Second-generation antidepressants for seasonal affective disorder. Cochrane Database Syst Rev. 2011 Dec 7;(12):CD008591. DOI:https://doi.org/10.1002/14651858.CD008591.pub2.
  • Golden RN, Gaynes BN, Ekstrom RD, et al. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry. 2005;162(4):656–662.
  • Benedetti F. Rate of switch from bipolar depression into mania after morning light therapy: a historical review. Psychiatry Res. 2018 Mar;261:351–356. Epub 2018 Jan 9. PMID: 29348073.
  • Modell JG, Rosenthal NE, Harriett AE, et al. Seasonal affective disorder and its prevention by anticipatory treatment with bupropion XL. Biol Psychiatry. 2005;58(8):658–667.
  • Niemegeers P, Dumont GJ, Patteet L, et al. Bupropion for the treatment of seasonal affective disorder. Expert Opin Drug Metab Toxicol. 2013 Sep;9(9):1229–1240.
  • Gartlehner G, Nussbaumer-Streit B, Gaynes BN, et al. Second-generation antidepressants for preventing seasonal affective disorder in adults. Cochrane Database Syst Rev. 2019 Mar 18;3(3):CD011268.
  • Nussbaumer-Streit B, Forneris CA, Morgan LC, et al. Light therapy for preventing seasonal affective disorder. Cochrane Database Syst Rev. 2019 Mar 18;3(3):CD011269. PMID: 30883670; PMCID: PMC6422319.
  • Nussbaumer-Streit B, Greenblatt A, Kaminski-Hartenthaler A, et al. Melatonin and agomelatine for preventing seasonal affective disorder. Cochrane Database Syst Rev. 2019 Jun 17;6(6):CD011271. PMID: 31206585; PMCID: PMC6578031.
  • Forneris CA, Nussbaumer-Streit B, Morgan LC, et al. Psychological therapies for preventing seasonal affective disorder. Cochrane Database Syst Rev. 2019 May24;5(5):CD011270. PMID: 31124141; PMCID: PMC6533196.
  • Cheung A, Dewa C, Michalak EE, et al. Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine. Depress Res Treat. 2012;2012:1–5.
  • Lam RW, Levitt AJ, editors. Canadian consensus guidelines for the treatment of seasonal affective disorder. Vancouver British Columbia: Clinical & Academic Publishing; 1999.
  • Nussbaumer-Streit B, Winkler D, Spies M, et al. Prevention of seasonal affective disorder in daily clinical practice: results of a survey in German-speaking countries. BMC Psychiatry. 2017 Jul 11;17(1):247. PMID: 28693583; PMCID: PMC5504611.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.